drugcoverage - Tasigna - Novartis Pharmaceuticals Canada Inc.

Medication Brand Name:

Tasigna

Active Ingredient:

nilotinib

DIN(s) in Canada:

02315874

francais

Manufacturer/Distributor:

Novartis Pharmaceuticals Canada Inc.

DrugCoverage Category:

Cancer

See Also:

Tasigna has been approved for funding in British Columbia (according to eligibility criteria) and is currently under review for funding in other provincies, territories and through the federal drug plans.Tasigna is an eligible benefit through some private insurance plans; however, a special authorization may be required in certain cases. The CML ALLIANCE^TM program is a specialized support program providing health information and financial assistance for eligible patients. For more information, please call 1 877 265 2554.

Coverage/Reimbursement by Private Insurance Plans in Canada
	Tasigna* is reimbursed through some private insurance plans; however, a special authorization may be required in certain cases. The CML ALLIANCE^TM program is a specialized support program providing health information and financial assistance for eligible patients. For more information, please call 1 877 265 2554.

Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province	Coverage	Program / Eligibility Criteria
BC		Tasigna is covered according to eligibility criteria through the B.C. Cancer Agency

Coverage/Reimbursement by Canadian Federal Plans
Plan	Coverage	Program / Eligibility Criteria
Public Services Health Care Plan		Tasigna may be covered by the PSHCP